Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women

被引:191
作者
Tamimi, Rulla M.
Byrne, Celia
Colditz, Graham A.
Hankinson, Susan E.
机构
[1] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Georgetown Univ, Lombardi Comprehens Canc Ctr, Canc Genet & Epidemiol Program, Washington, DC USA
[5] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2007年 / 99卷 / 15期
关键词
D O I
10.1093/jnci/djm062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Mammographic density and circulating sex hormones are two well-confirmed predictors of breast cancer risk. Whether mammographic density reflects levels of endogenous sex hormones is unclear. We examined whether these predictors are independently associated with breast cancer risk in a prospective study. Methods We conducted a nested case-control study within the Nurses' Health Study cohort of 253 case subjects with breast cancer and 520 control subjects. All participants were postmenopausal women who were not using postmenopausal hormones at the time of both blood collection and mammography. Plasma levels of estradiol, free estradiol, testosterone, and free testosterone were evaluated. Mammographic density was assessed by use of computer-assisted analysis of mammograms. Logistic regression models that were adjusted for matching variables and potential confounders were used to calculate relative risks (RRs) and 95% confidence intervals (Cls). All statistical tests were two-sided. Results Levels of circulating sex steroids and mammographic density were both statistically significantly and independently associated with breast cancer risk. The relative risk of breast cancer associated with mammographic density (RR for highest quartile compared with lowest quartile = 3.8, 95% Cl = 2.2 to 6.6; P-trend<.001) changed little when the analysis was adjusted for circulating estradiol (1111 = 3.9, 95% Cl = 2.2 to 6.9; P-trend<.001) or circulating testosterone (RR = 4.1, 95% Cl = 2.3 to 7.2; P-trend<-001). Circulating levels of estradiol (RR = 2.4, 95% Cl = 1.4 to 4.0) and of testosterone (RR = 2.0, 95% Cl = 1.2 to 3.1) were both associated with breast cancer risk, before and after adjustment for mammographic density. In a joint analysis of mammographic density and plasma testosterone, the risk of breast cancer was highest in the highest tertiles of both relative to the lowest tertiles of both (RR = 6.0, 95% Cl = 2.6 to 14.0). A similar pattern was observed in the joint analysis of estradiol and mammographic density (RR = 4.1, 95% Cl = 1.7 to 9.8). Conclusions Circulating sex steroid levels and mammographic density appear strongly and independently associated with the risk of breast cancer in postmenopausal women.
引用
收藏
页码:1178 / 1187
页数:10
相关论文
共 73 条
  • [1] CHROMATOGRAPHIC PURIFICATION OF ESTRADIOL-17BETA FOR USE IN RADIO-LIGAND ASSAY
    ABRAHAM, GE
    TULCHINSKY, D
    KORENMAN, SG
    [J]. BIOCHEMICAL MEDICINE, 1970, 3 (05): : 365 - +
  • [2] American College of Radiology, 2003, BREAST IMAG REP DAT
  • [3] Prospective breast cancer risk prediction model for women undergoing screening mammography
    Barlow, William E.
    White, Emily
    Ballard-Barbash, Rachel
    Vacek, Pamela M.
    Titus-Ernstoff, Linda
    Carney, Patricia A.
    Tice, Jeffrey A.
    Buist, Diana S. M.
    Geller, Berta M.
    Rosenberg, Robert
    Yankaskas, Bonnie C.
    Kerlikowske, Karla
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17): : 1204 - 1214
  • [4] CHARACTERISTICS OF RESPONDENTS AND NON-RESPONDENTS TO A MAILED QUESTIONNAIRE
    BARTON, J
    BAIN, C
    HENNEKENS, CH
    ROSNER, B
    BELANGER, C
    ROTH, A
    SPEIZER, FE
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1980, 70 (08) : 823 - 825
  • [5] Endogenous sex hormones, breast cancer risk, and tamoxifen response: An ancillary study in the NSABP Breast Cancer Prevention Trial (P-1)
    Beattie, MS
    Costantino, JP
    Cummings, SR
    Wickerham, DL
    Vogel, VG
    Dowsett, M
    Folkerd, EJ
    Willett, WC
    Wolmark, N
    Hankinson, SE
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (02): : 110 - 115
  • [6] Mammographic densities and the prevalence and incidence of histological types of benign breast disease
    Boyd, NF
    Jensen, HM
    Cooke, G
    Han, HL
    Lockwood, GA
    Miller, AB
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2000, 9 (01) : 15 - 24
  • [7] Heritability of mammographic density, a risk factor for breast cancer
    Boyd, NF
    Dite, GS
    Stone, J
    Gunasekara, A
    English, DR
    McCredie, MRE
    Giles, GG
    Tritchler, D
    Chiarelli, A
    Yaffe, MJ
    Hopper, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) : 886 - 894
  • [8] The association of breast mitogens with mammographic densities
    Boyd, NF
    Stone, J
    Martin, LJ
    Jong, R
    Fishel, E
    Yaffe, M
    Hammond, G
    Minkin, S
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (08) : 876 - 882
  • [9] QUANTITATIVE CLASSIFICATION OF MAMMOGRAPHIC DENSITIES AND BREAST-CANCER RISK - RESULTS FROM THE CANADIAN NATIONAL BREAST SCREENING STUDY
    BOYD, NF
    BYNG, JW
    JONG, RA
    FISHELL, EK
    LITTLE, LE
    MILLER, AB
    LOCKWOOD, GA
    TRITCHLER, DL
    YAFFE, MJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) : 670 - 675
  • [10] Brisson J, 2000, CANCER EPIDEM BIOMAR, V9, P911